Vikram Venkappayya Holla

Vikram Venkappayya Holla

Auto-generated profile, based on publicly available information

Vikram Venkappayya Holla

Department of Neurology, National Institute of Mental Health & Neurosciences, Karnataka, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
RVRajesh Verma
Rajesh Verma
RSRitesh Sahu
Ritesh Sahu
VHVikram Holla
Vikram Holla

13 November 2020 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MNManjunath Netravathi
Manjunath Netravathi
VHVikram Venkappayya Holla
Vikram Venkappayya Holla
ANAtchayaram Nalini
Atchayaram Nalini
RYRavi Yadav
Ravi Yadav
SVSeena Vengalil
Seena Vengalil
AMAnita Mahadevan
Anita Mahadevan

31 May 2020 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
SCSudhakar Pushpa Chaithra
Sudhakar Pushpa Chaithra
SPShweta Prasad
Shweta Prasad
VHVikram Venkappayya Holla
Vikram Venkappayya Holla
ASAlbert Stezin
Albert Stezin
NKNitish Kamble
Nitish Kamble
PPPramod Kumar Pal
Pramod Kumar Pal
Non-motor symptoms (NMSs) significantly contribute to increased morbidity and poor quality of life in patients with parkinsonian disorders. This study aims to explore the profile of NMSs in patients with progressive supranuclear palsy (PSP) using the validated Non-Motor Symptom Scale (NMSS). Seventy-six patients with PSP were evaluated in this study. Motor symptoms and NMSs were evaluated using the PSP Rating Scale (PSPRS), Unified Parkinson's Disease Rating Scale-III, Montreal Cognitive Assessment, Hamilton Depression (HAMD) and Anxiety Rating Scales, Parkinson's Disease Sleep Scale (PDSS) and NMSS. NMS severity and prevalence were also compared between patients with PSP-Richardson syndrome (PSP-RS) and those with PSP-parkinsonism. All subjects in this cohort reported at least 2 NMSs. The most prevalent NMSs in patients with PSP were in the domains of sleep/fatigue, mood/cognition, and sexual function. The least prevalent NMSs were in the domains of cardiovascular including falls, and perceptual problems/hallucinations. Significant correlations were observed between the NMSS scores and HAM-D, PDSS, PSPRS scores and PSPRS sub-scores. The severity of NMSs was unrelated to the duration of illness. Patients with PSP-RS reported a higher severity of drooling, altered smell/taste, depression and altered interest in sex and a higher prevalence of sexual dysfunction. NMSs are commonly observed in patients with PSP, and the domains of sleep, mood and sexual function are most commonly affected. These symptoms contribute significantly to disease morbidity, and clinicians should pay adequate attention to identifying and addressing these symptoms.

21 April 2022 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
VGValakunja Harikrishna Ganaraja
Valakunja Harikrishna Ganaraja
VHVikram V. Holla
Vikram V. Holla
ASAlbert Stezin
Albert Stezin
NKNitish Kamble
Nitish Kamble
RYRavi Yadav
Ravi Yadav
PPPramod Kumar Pal
Pramod Kumar Pal
Introduction: Spinocerebellar ataxia type-12 (SCA12) is a rare form of SCA, most commonly reported from the Indian Agarwal and related families. In this study we describe the clinical, genetic, and radiological characteristics of a sizeable cohort of genetically proven SCA12.Methods: A retrospective chart-review of the genetically confirmed SCA12 patients from our centre. The demographic, clinical, and investigation findings were reviewed. Correlation of expanded repeats length with various demographic and clinical features were studied.Results: A total of 49 patients (34 males, 42 families) were included of which 79.6% belonged to Agarwal community. The mean age at onset and age at presentation were 46.38 ± 11.7 years and 53.16 ± 12.78 years respectively. The most common initial symptom was tremor (73.5%), followed by ataxia (18.4%). At presentation, 95.9% of the patients had tremor with predominant distribution in the bilateral upper limbs (85.7%). At presentation, 73.5% of patients had ataxia and 22.4% had cognitive dysfunction. The mean CAG repeat length in PPP2R2B in the expanded allele was 53.26 ± 6.10 (40–72). The lowest pathogenic expanded repeat sizes in PPP2R2B recorded in our cohort was 40 & 42 repeats from two patients with a consistent clinical phenotype. Another unusual phenotype was the presence of prominent myoclonus. There was no significant correlation between the age at onset of symptoms and the repeat size of CAG repeat.Conclusion: SCA12 is not confined to a single ethnicity. Upper limb tremor and ataxia were the most common presentation. Unusual presentation may cause diagnostic confusion especially when recorded in patients from non-Aggarwal families.

16 March 2021 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
PRPritam Raja
Pritam Raja
BSBiswas Shamick
Biswas Shamick
NKNitish Kamble
Nitish Kamble
VHVikram Venkappayya Holla
Vikram Venkappayya Holla
PPP. K. Pal
P. K. Pal
MNM. Netravathi
M. Netravathi

15 May 2024 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
DGDivyani Garg
Divyani Garg
SPSahil Patel
Sahil Patel
CSCharulata S. Sankhla
Charulata S. Sankhla
VHVikram V. Holla
Vikram V. Holla
VPVijayashankar Paramanandam
Vijayashankar Paramanandam
PPPramod K. Pal
Pramod K. Pal